Trial Profile
An Open Label Safety Study of COV795 in Subjects With Osteoarthritis or Chronic Low Back Pain.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Sep 2020
Price :
$35
*
At a glance
- Drugs Oxycodone/paracetamol (Primary)
- Indications Back pain; Osteoarthritis
- Focus Adverse reactions; Registrational
- Sponsors Mallinckrodt LLC
- 03 May 2014 Tolerability results from a pooled analysis of two phase III trials presented at the 33rd Annual Scientific Meeting of the American Pain Society.
- 29 May 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 09 Feb 2012 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.